-
The recent case of a 12-year-old boy named Motl Brody brought attention not only to the occasional dilemmas presented by the designation of brain death, but also how to address faith traditions in determining death.
-
On Nov. 4, 2008, Washington state voters passed a ballot initiative giving terminally ill patients with six months to live the right to have a physician prescribe lethal drugs for the patient to self-administer to bring about his or her death.
-
United Kingdom's Baroness Mary Warnock, considered an expert on medical ethics, created a stir in late 2008 with her suggestion that those in the UK with dementia have a duty to die, so as not to strain public health resources.
-
The House of Delegates of the American Medical Association (AMA) in Chicago at its November 2008 meeting in Orlando voted to ask The Joint Commission for a moratorium on its disruptive physicians policy, introduced in July 2008 and scheduled to take effect Jan. 1, 2009. A decision on the matter was not reached prior to press time.
-
Clinical trial (CT) sites should be providing research nurses and other staff with the best possible foundation in clinical research ethics, as well as helping them make the transition from clinical care to research trials, experts say.
-
One ethical dilemma nurses face when they move from clinical care to clinical research (CR) is the way the two fields' missions are different with regard to patients.
-
"Defining Wisdom," a project of The University of Chicago across multiple disciplines, awarded Lauris Kaldjian, MD, PhD, in 2008 a grant to develop a framework for medical decision making.
-
While brain death is widely accepted as a way of defining when death has occurred, this determination, or category of death, can create its own set of problems.
-
In one sense, undocumented patients are like any other patients some have health insurance, but many will not. Whats particularly challenging is that undocumented patients who are uninsured will usually not qualify for the safety net programs that provide assistance for similar patients with citizenship, says Mark Kuczewski, PhD, chair of the Department of Medical Education and director of the Neiswanger Institute for Bioethics at Loyola University in Maywood, IL.
-
Blogs, message boards, and patient communities are being used not only by patients, but also by research participants. In some cases, this reveals whether or not a participant is taking actual medication or placebos, compromising the studys validity.